Research released by the state's Health Policy commission Thursday showed number of Massachusetts residents prescribed a relatively new class of weight management and diabetes drugs has increased sevenfold over five years. The medications include the brand name drugs Ozempic, Wegovy and Mounjaro.
The number of Massachusetts residents prescribed a relatively new class of drugs used for diabetes and weight management has increased sevenfold over five years, at a staggering cost, according to a new report from the state Health Policy Commission.
The drugs are prescribed for conditions such as type 2 diabetes and obesity, and patients typically self-inject weekly or daily. National data suggests net sales of the drugs in the U.S. totaled $5.9 billion in the second quarter of 2023. The average cost of the medications in the U.S. is $1,000 per month, much higher than in other countries.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Scottsdale Research Institute leads global 'magic mushroom' research studyMultiple groups successfully advocated for the Legislature to approve the grant
Read more »
Senate panel to weigh Novo Nordisk subpoena on Ozempic, Wegovy pricesThe U.S. Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S. prices for weight loss drugs Ozempic and Wegovy, which are far higher than those in other countries.
Read more »
Ozempic vs Krispy Kreme: Wall Street firm bets weight-loss drugs won’t beat doughnut salesWall Street firm Truist Securities is betting that consumers will still buy Krispy Kreme doughnuts amid the surge in weight-loss drugs like Novo Nordisk's Ozempic.
Read more »
Ozempic, Wegovy scams skyrocket as demand surges for expensive weight loss drugsScams targeting weight loss-related drugs such as Ozempic and Wegovy have proliferated, putting consumers who are seeking to purchase the medication at serious risk.
Read more »
Weight-loss drugs are forcing changes to grocery store offeringsNew food options targeting people taking drugs like Ozempic may change diets more broadly.
Read more »
What You Should Know Before Taking Popular Weight Loss Drugs Like Ozempic And WegovyDr. Omer Awan MD MPH CIIP is a practicing radiologist physician in Baltimore, MD that writes about healthcare and public health. He earned his Medical Doctor (MD) degree from the George Washington University School of Medicine and Health Sciences and his Master in Public Health (MPH) degree from Harvard University.
Read more »